Quarterly report [Sections 13 or 15(d)]

Share-Based Expense

v3.25.2
Share-Based Expense
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Share-Based Expense

 

7. Share-Based Expense

 

Total share-based expense related to stock options and restricted stock units (“RSUs”) was approximately $16,000 and $42,000 for the three months ended June 30, 2025 and 2024, respectively, and approximately $35,000 and $0.1 million for the six months ended June 30, 2025 and 2024, respectively.

 

Share-based expense is classified in the condensed consolidated statements of operations as follows: 

                       
    Three Months Ended June 30,     Six Months Ended June 30,  
    2025     2024     2025     2024  
Research and development expenses   $     $ (3,804 )   $     $ 11,433  
General and administrative expenses     15,683       45,900       34,934       107,737  
    $ 15,683     $ 42,096     $ 34,934     $ 119,170  

 

Employee Stock Options and RSU’s

 

No stock option awards to purchase shares of common stock were granted during the three and six months ended June 30, 2025. During the three and six months ended June 30, 2024, 20,000 stock options to purchase shares of common stock were granted by the Company. No RSUs were granted during each of the three and six months ended June 30, 2025 and 2024. The Company recognized a total of approximately $16,000 and $42,000 of share-based expense related to employee stock options during the three months ended June 30, 2025 and 2024, respectively, and approximately $35,000 and $0.1 million during the six months ended June 30, 2025 and 2024, respectively. No employee stock options or RSUs were exercised during the three and six months ended June 30, 2025. The Company issued 417 shares of common stock during the three and six months ended June 30, 2024 related to RSUs representing all RSUs outstanding. No employee stock options were exercised during the three and six months ended June 30, 2024. During the three and six months ended June 30, 2025, options to purchase 64,062 shares and 89,878 shares of common stock expired. During the three and six months ended June 30, 2024, stock options to purchase 11,667 shares of common stock were forfeited.

 

Non-Employee Stock Options

 

There were no non-employee stock options granted or exercised during each of the three and six months ended June 30, 2025 and 2024. No non-employee stock option grants expired during each of the three and six months ended June 30, 2025 and 2024. The Company did not recognize any expense related to non-employee stock options during each of the three and six months ended June 30, 2025 and 2024.